Menu
Not yet recruiting NCT07352397

Inhaled Lavender Oil, Rosemary Oil, and Their Combination in Reducing Dental Anxiety and Pain in Pediatric Dental Patients

No phase Interventional Dental Anxiety

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Lavender group, Rosemary group, Combination of both lavender and rosemary, No essential oils.
Who it may be relevant to
Registry conditions: Dental Anxiety. Basic parameters: 6 years — 9 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Egypt
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

The Effect of Inhaled Lavender Oil, Rosemary Oil, and Their Combination in Reducing Dental Anxiety and Pain in Pediatric Dental Patients (A Randomized Controlled Clinical Trial)

Overview

Background: Dental anxiety and pain are common concerns in pediatric dentistry. These issues can lead to negative experiences for children and can make it difficult for them to cooperate during treatment. While medications can help manage these symptoms, it can also have side effects. This highlights the need for safe and effective complementary treatments. Aromatherapy, particularly with lavender and rosemary oils, has demonstrated anxiolytic and analgesic properties in different fields. However, their effect in helping children cope with dental anxiety and pain during procedures requiring local anesthesia has not yet been thoroughly studied. Purpose: This study aims to investigate the efficacy of inhaled lavender oil, rosemary oil, and their combination in reducing dental anxiety and pain in children receiving local anesthesia for extraction of lower primary molar

Interventions

  • Other Lavender group
    Children in this group will be inhaled 0.5 ml of prepared mixture (of Lavandula Angustifolia+ Sweet Almond carrier oil ) on a cotton pad attached to the facial steamer .
  • Other Rosemary group
    Children in this group will be inhaled 0.5 ml of prepared mixture (of Rosmarinus Officinalis + Sweet Almond carrier oil ) on a cotton pad attached to the facial steamer
  • Other Combination of both lavender and rosemary
    Children in this group would be inhaled 0.5 ml of prepared mixture (of Lavandula Angustifolia and Rosmarinus Officinalis + Sweet Almond carrier oil) on a cotton pad attached to the facial steamer .
  • Other No essential oils
    Children in this group will be inhaled 0.5 mL of the carrier oil (Sweet Almond ) on a cotton pad attached to the facial steamer .

Primary outcome measures

  • Change in anxiety scores [Time frame: up to 1 week]
Secondary outcome measures (3)
  • Change in anxiety scores (by children) [Time frame: up to 1 week]
  • Change in pain scores [Time frame: up to 1 week]
  • Change in heart rate [Time frame: During procedure]

Eligibility criteria

Inclusion criteria

  • Frankl behavioural rating score 2 or 3 during preoperative assessment.
  • Healthy children ASAI.
  • Children without a previous dental history.
  • Children presenting with at least one mandibular molar indicated for extraction. (43)
  • Completion of the written informed consent form by parents/guardian.

Exclusion criteria

  • Children with colds, asthma, and any other respiratory diseases.
  • Children who took NSAIDs or analgesic drugs in the last 8 hours before treatment.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Double blind
Primary purpose
Treatment

Study locations

Egypt · 1 center
  • Alexandria Faculty of Dentistry — Alexandria

Identifiers

NCT: NCT07352397 · 1188-11/2025

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗